Introduction: Peripheral joint osteoarthritis (OA) in Australia is the third leading cause of life-years lost. Implant surgery is a great help, but patients who are waiting or are inoperable suffer. Low Dose Radiotherapy (LDRT) is well established in some countries. Three-dimensional conformal radiotherapy (3DCRT) is recommended. However, some departments may only have Volumetric Modulated Arc Therapy (VMAT). We present our experiences treating ten volumes of symptomatic OA treated with VMAT in nine consecutive patients to two months post-LDRT. Methods: The hypothesis was that LDRT using VMAT was feasible and effective at two months. Patient response data was collected prospectively. The Visual Analog Scale Pain (VASP) for pain was used. A Visual Analog Scale Mobility (VASM) was created for mobility. Bones within radiation oncologists (RO) skin marks around the joint were auto-contoured for clinical target volume (CTV) with 2 mm expansion to planning target volume (PTV). Treatment was titrated to clinical response. Phase 1 was 3 Gray (Gy) in 6 fractions at 2-3 fractions per week. There was RO review at 2 months post-phase 1 for consideration of phase 2. If no response, then phase 2 was 6 Gy in 6 fractions, if a partial response (PR), then a repeat of phase 1. A third phase similar to phase 2 was possible. RO follow-up was done 2 months after the last phase. Results: Nine consecutive patients, eight males and one female, average age of 69 years (60-84), with ten volumes of symptomatic OA were treated. Joints were three single knees, two cases of both knees, three cases of both hands, one hip and one carpometacarpal joint. They had suffered from OA for an average of eight years (1-20). All were on at least one systemic therapy. All were using some sort of local therapy or device. Eight had a PR to phase 1 and proceeded to phase 2. Two had an equivocal response. No patient had a third phase. Average VASP pain scores fell from baseline of 7.4 to 3.6 after phase 1, and to 2.3 after phase 2. Average VASM immobility scores fell from baseline of 6.9 to 4.4 after phase 1 and to 3.3 after phase 2. Conclusion: In this small Australian cohort LDRT using VMAT is feasible and clinically effective when measured at 2 months. More study is needed.
Read full abstract